How KOLs Prefer to Engage During COVID-19

H1 and the Medical Science Liaison Society conducted a survey with 475 KOLs in the USA across 21 specialties to gain insights to help the MSL community be more effective during this uncertain and ever-evolving period.

On August 11th, 2020 three distinguished panelists Debra Kronschnabel, PharmD, Head North American Medical Scientists and Medical Capability of ViiV, Ariel Katz, CEO of H1, and Samuel Dyer, CEO of Medical Science Liaison Society, conducted a live webinar where they discussed the results of the recently conducted “How KOLs Prefer to Engage with MSLs During the COVID-19 Pandemic” survey.


Trusted by the top Medical Affairs companies in the world, H1 has the most accurate and most updated data in healthcare today.

Further reading: Why Physicians May Want to Become Key Opinion Leaders.